BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 22466077)

  • 1. Undertreatment of Asian chronic hepatitis B patients on the basis of standard guidelines: a community-based study.
    Zhang S; Ristau JT; Trinh HN; Garcia RT; Nguyen HA; Nguyen MH
    Dig Dis Sci; 2012 May; 57(5):1373-83. PubMed ID: 22466077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low treatment rates in patients meeting guideline criteria in diverse practice settings.
    Kim LH; Nguyen VG; Trinh HN; Li J; Zhang JQ; Nguyen MH
    Dig Dis Sci; 2014 Sep; 59(9):2091-9. PubMed ID: 25060778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rates of Treatment Eligibility in Follow-Up of Patients with Chronic Hepatitis B (CHB) Across Various Clinical Settings Who Were Initially Ineligible at Presentation.
    Uribe LA; Nguyen N; Kim L; Trinh HN; Wong C; Wong C; Nguyen LH; Nguyen MH
    Dig Dis Sci; 2016 Feb; 61(2):618-25. PubMed ID: 26660679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic hepatitis B treatment eligibility and actual treatment rates in patients in community gastroenterology and primary care settings.
    Nguyen VG; Wan K; Trinh HN; Li J; Zhang JQ; Nguyen MH
    J Clin Gastroenterol; 2015 Feb; 49(2):145-9. PubMed ID: 25014233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment eligibility of patients with chronic hepatitis B initially ineligible for therapy.
    Nguyen NH; Nguyen V; Trinh HN; Lin B; Nguyen MH
    Clin Gastroenterol Hepatol; 2013 May; 11(5):565-71. PubMed ID: 23333662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poor adherence to AASLD guidelines for chronic hepatitis B Management and treatment in a large academic medical center.
    Wu Y; Johnson KB; Roccaro G; Lopez J; Zheng H; Muiru A; Ufere N; Rajbhandari R; Kattan O; Chung RT
    Am J Gastroenterol; 2014 Jun; 109(6):867-75. PubMed ID: 24732869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic hepatitis B management based on standard guidelines in community primary care and specialty clinics.
    Ku KC; Li J; Ha NB; Martin M; Nguyen VG; Nguyen MH
    Dig Dis Sci; 2013 Dec; 58(12):3626-33. PubMed ID: 24122622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics and management of patients with chronic hepatitis B in an integrated care setting.
    Sarkar M; Shvachko VA; Ready JB; Pauly MP; Terrault NA; Peters MG; Manos MM
    Dig Dis Sci; 2014 Sep; 59(9):2100-8. PubMed ID: 24728968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence to chronic hepatitis B treatment guideline recommendations for laboratory monitoring of patients who are not receiving antiviral treatment.
    Juday T; Tang H; Harris M; Powers AZ; Kim E; Hanna GJ
    J Gen Intern Med; 2011 Mar; 26(3):239-44. PubMed ID: 20978862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of advanced practice providers on characteristics and quality of care of patients with chronic hepatitis B.
    Kam LY; Huang DQ; Tobias AF; Poon K; Henry L; Kwo P; Cheung R; Nguyen MH
    Aliment Pharmacol Ther; 2022 Dec; 56(11-12):1591-1601. PubMed ID: 36266768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simplifying Treatment Criteria in Chronic Hepatitis B: Reducing Barriers to Elimination.
    Wong RJ; Kaufman HW; Niles JK; Kapoor H; Gish RG
    Clin Infect Dis; 2023 Feb; 76(3):e791-e800. PubMed ID: 35594550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Similar efficacy and safety of tenofovir in Asians and non-Asians with chronic hepatitis B.
    Pan CQ; Chan S; Trinh H; Yao A; Bae H; Lou L
    World J Gastroenterol; 2015 May; 21(18):5524-31. PubMed ID: 25987775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B surface antigen loss and sustained viral suppression in Asian chronic hepatitis B patients: A community-based real-world study.
    Wong RJ; Nguyen MT; Trinh HN; Chan C; Huynh A; Ly MT; Nguyen HA; Nguyen KK; Torres S; Yang J; Liu B; Garcia RT; Bhuket T; Baden R; Levitt B; da Silveira E; Gish RG
    J Viral Hepat; 2017 Dec; 24(12):1089-1097. PubMed ID: 28581644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Comparison Between Community and Academic Practices in the USA in the Management of Chronic Hepatitis B Patients Receiving Entecavir: Results of the ENUMERATE Study.
    Lee HM; Ahn J; Kim WR; Lim JK; Nguyen M; Pan CQ; Kim D; Mannalithara A; Te H; Trinh H; Chu D; Tran T; Woog J; Lok AS
    Dig Dis Sci; 2019 Feb; 64(2):358-366. PubMed ID: 30238203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy of international guidelines for identifying significant fibrosis in hepatitis B e antigen--negative patients with chronic hepatitis.
    Sanai FM; Babatin MA; Bzeizi KI; Alsohaibani F; Al-Hamoudi W; Alsaad KO; Al Mana H; Handoo FA; Al-Ashgar H; Alghamdi H; Ibrahim A; Aljumah A; Alalwan A; Altraif IH; Al-Hussaini H; Myers RP; Abdo AA
    Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1493-1499.e2. PubMed ID: 23811251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of chronic hepatitis B phases in Eritrean patients: a laboratory-based cross-sectional study.
    Hamida ME; Raja SM; Seyoum Y; Elkhidir IM; Tekle F
    BMC Gastroenterol; 2021 May; 21(1):198. PubMed ID: 33933017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost of treating chronic hepatitis B: comparison of current treatment guidelines.
    Robotin M; Patton Y; Kansil M; Penman A; George J
    World J Gastroenterol; 2012 Nov; 18(42):6106-13. PubMed ID: 23155339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum Alanine Aminotransferase and Hepatitis B DNA Flares in Pregnant and Postpartum Women with Chronic Hepatitis B.
    Chang CY; Aziz N; Poongkunran M; Javaid A; Trinh HN; Lau D; Nguyen MH
    Am J Gastroenterol; 2016 Oct; 111(10):1410-1415. PubMed ID: 27456990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation of treatment recommendations for chronic hepatitis B in patients attending specialized hospital care in Denmark - a region wide study.
    Bollerup S; Hallager S; Baek O; Krarup H; Madsen LG; Thielsen P; Balslev U; Mens H; Barfod T; Rye Clausen M; Hobolth L; Gerstoft J; Weis N
    Scand J Gastroenterol; 2020 Jul; 55(7):843-847. PubMed ID: 32568561
    [No Abstract]   [Full Text] [Related]  

  • 20. Performance of risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B) score in classifying treatment eligibility under 2012 Asian Pacific Association for the Study of the Liver (APASL) guideline for chronic hepatitis B patients.
    Chen TM; Chang CC; Huang PT; Wen CF; Lin CC
    Aliment Pharmacol Ther; 2013 Jan; 37(2):243-51. PubMed ID: 23171385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.